From 2004 through 2005, Frank was
with Igeneon AG, an Austrian clinical stage biopharma company, which in
late 2004 was acquired by Aphton Corp., a public biotech company based
in Philadelphia, USA.
Before joining Igeneon, he held various senior communications positions
within Baxter, the pharma and medical devices company, with
responsibilities in Germany, Austria, and Europe.
Frank joined the life science industry in 1990 when he resumed a PR
responsibility with the German Pharmaceutical Industry Association BPI.
Prior to that he had served as a business editor of one of
Austria’s leading dailies.
He holds a master’s degree in history from Vienna University.
He has been certified by the Investor Relations Society